Crossref
TCT-422 LVEF Recovery Persists Beyond Six Months After CTO-PCI - Insights Across the Spectrum of Ischemic Cardiomyopathy
JACC · 2026-11 · 88 (18) · B180
DOI: 10.1016/j.jacc.2026.09.536 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-11. Verfasst von Adham Ramadan und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ramadan, A., Doma, M., Cogar, B., Mashayekhi, K., McEntegart, M., Alaswad, K., Leibundgut, G., Rinfret, S., Brilakis, E., & Megaly, M. (2026). TCT-422 LVEF Recovery Persists Beyond Six Months After CTO-PCI - Insights Across the Spectrum of Ischemic Cardiomyopathy. JACC, 88(18), B180. https://doi.org/10.1016/j.jacc.2026.09.536
Vancouver
Ramadan A, Doma M, Cogar B, Mashayekhi K, McEntegart M, Alaswad K, et al. TCT-422 LVEF Recovery Persists Beyond Six Months After CTO-PCI - Insights Across the Spectrum of Ischemic Cardiomyopathy. JACC. 2026;88(18):B180. doi:10.1016/j.jacc.2026.09.536
BibTeX
@article{Ramadan2026,
author = {Ramadan, Adham and Doma, Mohamed and Cogar, Bryan and Mashayekhi, Kambis and McEntegart, Margaret and Alaswad, Khaldoon and Leibundgut, Gregor and Rinfret, Stephane and Brilakis, Emmanouil and Megaly, Michael},
title = {TCT-422 LVEF Recovery Persists Beyond Six Months After CTO-PCI - Insights Across the Spectrum of Ischemic Cardiomyopathy},
journal = {JACC},
year = {2026},
volume = {88},
number = {18},
pages = {B180},
doi = {10.1016/j.jacc.2026.09.536}
}
EUVIMED